Midiclinic
Board
1 director, last change in November 2026Director (not named in the articles)
appointed by deed of 19-09-2024
term without a fixed end
earlier director, until 01-09-2023
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 31-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 19-09-2024
Mandates through the years
4 names, the dashed line is todayAhkim Abdsamad
Director (not named in the articles)
Director (not named in the articles)
TFEILI Ghassan
Director (not named in the articles)
Director (not named in the articles)
Benali Karima
Director
Director
Leuridan Timothée
Manager
Manager
BoardEarliermandate already running before its first mention
Mandates as a list
- Ahkim Abdsamad
- Manager, appointed by deed of 13-08-2020, until 01-09-2023
- Director (not named in the articles), appointed by deed of 19-09-2024, still in office
- TFEILI Ghassan
- Director (not named in the articles), appointed by deed of 19-09-2024, until 03-11-2026
- Benali Karima
- Director, appointed by deed of 23-11-2023, until 19-09-2024
- Leuridan Timothée
- Manager, until 10-07-2020
Control
Capital
- Contribution
- €18,600
- Shares
- 186
- Contribution per share
- €100
- Equity per share
- -€334 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 19-09-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Indien de vennootschap maar één aandeelhouder meer telt, kan deze het geheel of een deel van de aandelen vrij overdragen”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of June at 15:00
Shareholders
Share transfer
deed of 03-11-2026 ↗